Rick Kaplan
London, ENG WC1V6LJ, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Adapting the design of the ongoing RAMPART trial in response to external evidence: An example for trials which take many years to run and report.
Journal: Contemporary clinical trials communications
Published: October 16, 2023
External Validation of the 2003 Leibovich Prognostic Score in Patients Randomly Assigned to SORCE, an International Phase III Trial of Adjuvant Sorafenib in Renal Cell Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 25, 2022
RAMPART: A model for a regulatory-ready academic-led phase III trial in the adjuvant renal cell carcinoma setting.
Journal: Contemporary clinical trials
Published: March 18, 2021
RAMPART: A phase III multi-arm multi-stage trial of adjuvant checkpoint inhibitors in patients with resected primary renal cell carcinoma (RCC) at high or intermediate risk of relapse.
Journal: Contemporary clinical trials
Published: March 18, 2021
Adjuvant Sorafenib for Renal Cell Carcinoma at Intermediate or High Risk of Relapse: Results From the SORCE Randomized Phase III Intergroup Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 14, 2020
Metformin use and risk of cancer in patients with type 2 diabetes: a cohort study of primary care records using inverse probability weighting of marginal structural models.
Journal: International journal of epidemiology
Published: January 21, 2019
Changing the Paradigm—Multistage Multiarm Randomized Trials and Stratified Cancer Medicine.
Journal: The oncologist
Published: January 14, 2015
Showing 1-7 of 7
Last Updated: 09/26/2026